HeartSciences (HSCS) Projected to Post Quarterly Earnings on Monday

HeartSciences (NASDAQ:HSCSGet Free Report) will likely be issuing its quarterly earnings data before the market opens on Monday, August 4th. Analysts expect the company to announce earnings of ($2.51) per share for the quarter.

HeartSciences (NASDAQ:HSCSGet Free Report) last announced its earnings results on Thursday, July 24th. The company reported ($1.88) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($2.51) by $0.63. On average, analysts expect HeartSciences to post $-10 EPS for the current fiscal year and $-9 EPS for the next fiscal year.

HeartSciences Stock Down 2.2%

Shares of HSCS opened at $3.05 on Friday. The business’s 50 day moving average is $3.81 and its two-hundred day moving average is $3.50. HeartSciences has a 52-week low of $2.36 and a 52-week high of $6.47. The firm has a market cap of $3.30 million, a price-to-earnings ratio of -0.33 and a beta of 2.57.

Analysts Set New Price Targets

Separately, Wall Street Zen raised HeartSciences to a “sell” rating in a research report on Saturday, July 26th.

Check Out Our Latest Research Report on HSCS

HeartSciences Company Profile

(Get Free Report)

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.

Further Reading

Earnings History for HeartSciences (NASDAQ:HSCS)

Receive News & Ratings for HeartSciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HeartSciences and related companies with MarketBeat.com's FREE daily email newsletter.